ESC 365 - Effect of ferric carboxymaltose on LVEF as assessed by cardiac MRI in patients with chronic heart failure and iron deficiency: a randomized, double-blinded, placebo-controlled, dual-center trial

HFA Premium Access

Effect of ferric carboxymaltose on LVEF as assessed by cardiac MRI in patients with chronic heart failure and iron deficiency: a randomized, double-blinded, placebo-controlled, dual-center trial

Session: Moderated Poster Session - Chronic heart failure

Topic: Pharmacotherapy

Speaker: Doctor M. Karakas (Hamburg, DE)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

3 presentations

0 follower

8 more presentations in this session

Association between heart failure medication at discharge and heart failure readmission

Speaker: Doctor G. Linssen (Almelo, NL)

Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis involving 48,628 patients

Speaker: Doctor C. Kapelios (Athens, GR)

Combined effects of growth hormone and testosterone replacement treatment in heart failure

Speaker: Doctor A. Salzano (Naples, IT)

FE- IRON (First Ever Irish heart failure nurses group Review On implementation of ESC iroN guideline in Ireland)

Speaker: Ms M. Carey (Dublin, IE)

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in HFrEF.

Speaker: Doctor P. Martens (Genk, BE)

Access the full session

Moderated Poster Session - Chronic heart failure

Speakers: Doctor M. Karakas, Doctor G. Linssen, Doctor C. Kapelios, Doctor A. Salzano, Ms M. Carey...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources